Vergelijking
Dulaglutide vs. Eloralintide
Twee peptiden naast elkaar — identiteit, bewijsbasis, juridische status en bekende bijwerkingen.
Identiteit
Categorie
Metabool
Metabool
CAS-nr.
923950-08-7
geen gegevens
Molecuulmassa
59670 g/mol
geen gegevens
Halfwaardetijd
110 h
geen gegevens
Sequentie
GLP-1(7-37)-Variante kovalent verbunden mit modifiziertem humanen IgG4-Fcgeen gegevens
Werkingsmechanisme
Dulaglutide
Dulaglutide consists of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc. The Fc fusion increases molecular weight substantially (~60 kDa), reduces renal filtration and extends the half-life to several days. GLP-1 receptor activation glucose-dependently stimulates insulin secretion, inhibits glucagon, delays gastric emptying and modulates central satiety signalling.
Eloralintide
Eloralintide selectively activates amylin receptors (preferentially AMY1R) and promotes satiety. The approach targets weight loss via the amylin axis, complementary to or independent of GLP-1 agents.
Bewijsbasis
Hoogste bewijs
Humane RCT
Humane RCT
Studies
5
2
waarvan bij mensen
5
1
Geregistreerde effecten
3
2
Openstaande tegenstrijdigheden
1
0
Gedocumenteerde bijwerkingen
2
1
Juridische status
Volledige vermeldingen
Frequently asked questions
- What is the difference between Dulaglutide and Eloralintide?
- Dulaglutide is classified as "Metabool", while Eloralintide is classified as "Metabool". Dulaglutide: GLP-1 receptor agonist designed as a fusion protein of two modified GLP-1(7-37) sequences covalently linked to a human IgG4-Fc fragment. FDA-approved 2014 (Trulicity) for type 2 diabetes; EMA approval 2014. Eloralintide: Eloralintide is a selective, long-acting amylin receptor agonist from Eli Lilly for once-weekly subcutaneous use — under investigation for obesity, alone and combined with incretin therapy. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Dulaglutide or Eloralintide?
- The highest available evidence level is "Humane RCT" for Dulaglutide and "Humane RCT" for Eloralintide. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Dulaglutide and Eloralintide in Germany and the United States?
- Duitsland: Dulaglutide — Op recept, Eloralintide — Niet goedgekeurd. Verenigde Staten: Dulaglutide — Op recept, Eloralintide — Niet goedgekeurd. These are factual summaries with source and review date on the individual pages.